Paclitaxel-associated reticulate hyperpigmentation: Report and review of chemotherapy-induced reticulate hyperpigmentation

doi:10.12998/wjcc.v4.i12.390

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (13610)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-10) series, Tables (1-2) series.

Item

Count

PDF

466

WORD

385

HTML

9002

Figures (1-10)

879

Tables (1-2)

286

Sum=11018

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1079

Download

1513

Sum=2592

Dec 16, 2016 (publication date) through Jan 11, 2025

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Dec 16, 2016; 4(12): 390-400
Published online Dec 16, 2016. doi: 10.12998/wjcc.v4.i12.390

Full Size Figure Download Figure

Figure 10 The paclitaxel-associated interface dermatitis lesion on the right ankle progressed in severity and distribution. A similar lesion also developed on the left ankle.

Citation: Cohen PR. Paclitaxel-associated reticulate hyperpigmentation: Report and review of chemotherapy-induced reticulate hyperpigmentation. World J Clin Cases 2016; 4(12): 390-400
URL: https://www.wjgnet.com/2307-8960/full/v4/i12/390.htm
DOI: https://dx.doi.org/10.12998/wjcc.v4.i12.390